Insertable Cardiac Monitor for Primary Atrial Fibrillation Detection in High-Risk Heart Failure Patients
A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 477 participants.
Also called NCT04818645
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose prevention
- Phase
- Not applicable
- Enrolled
- 477 participants
- Sponsor
- Registry
-
NCT04818645
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT04818645. Randomized; single masking; primary purpose prevention. Start 2023-01-31 (actual); primary completion 2028-07-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Insertable Cardiac Monitor for Primary Atrial Fibrillation Detection in High-Risk Heart Failure Patients
- Acronym
- ASSERT-AF
- Condition
- Atrial Fibrillation
- Condition
- Heart Failure
- Intervention (Device)
- ASSERT Insertable Cardiac Monitor
- Intervention (Other)
- Conventional Management and monitoring
- Lead sponsor
- University of Rochester
- Collaborator
- Abbott
Record details
- Record id
cardio:ct-nct04818645- Content hash
8389757525f795e96711c8e2c4cb9489f7d03be0aaa857537c5c70a2e52e2026